BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34485012)

  • 1. Abnormal VLCADD newborn screening resembling MADD in four neonates with decreased riboflavin levels and VLCAD activity.
    Hagemeijer MC; Oussoren E; Ruijter GJG; Onkenhout W; Huidekoper HH; Ebberink MS; Waterham HR; Ferdinandusse S; de Vries MC; Huigen MCDG; Kluijtmans LAJ; Coene KLM; Blom HJ
    JIMD Rep; 2021 Sep; 61(1):12-18. PubMed ID: 34485012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and cellular pathology of very-long-chain acyl-CoA dehydrogenase deficiency.
    Schiff M; Mohsen AW; Karunanidhi A; McCracken E; Yeasted R; Vockley J
    Mol Genet Metab; 2013 May; 109(1):21-7. PubMed ID: 23480858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and Clinical Investigations on Portuguese Patients with Multiple acyl-CoA Dehydrogenase Deficiency.
    Henriques BJ; Lucas TG; Martins E; Gaspar A; Bandeira A; Nogueira C; Brandão O; Rocha H; Vilarinho L; Gomes CM
    Curr Mol Med; 2019; 19(7):487-493. PubMed ID: 31418342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavin adenine dinucleotide synthase deficiency due to FLAD1 mutation presenting as multiple acyl-CoA dehydrogenation deficiency-like disease: A case report.
    Yamada K; Ito M; Kobayashi H; Hasegawa Y; Fukuda S; Yamaguchi S; Taketani T
    Brain Dev; 2019 Aug; 41(7):638-642. PubMed ID: 30982706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent ACADVL molecular findings in individuals with a positive newborn screen for very long chain acyl-coA dehydrogenase (VLCAD) deficiency in the United States.
    Miller MJ; Burrage LC; Gibson JB; Strenk ME; Lose EJ; Bick DP; Elsea SH; Sutton VR; Sun Q; Graham BH; Craigen WJ; Zhang VW; Wong LJ
    Mol Genet Metab; 2015 Nov; 116(3):139-45. PubMed ID: 26385305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal vitamin deficiency mimicking multiple acyl-CoA dehydrogenase deficiency on newborn screening.
    Gramer G; Hoffmann GF; Hennermann JB
    Mol Genet Metab Rep; 2021 Jun; 27():100738. PubMed ID: 33732619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening.
    Merritt JL; Vedal S; Abdenur JE; Au SM; Barshop BA; Feuchtbaum L; Harding CO; Hermerath C; Lorey F; Sesser DE; Thompson JD; Yu A
    Mol Genet Metab; 2014 Apr; 111(4):484-92. PubMed ID: 24503138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of exonic variants of uncertain significance in very long-chain acyl-CoA dehydrogenase identified through newborn screening.
    D'Annibale OM; Koppes EA; Sethuraman M; Bloom K; Mohsen AW; Vockley J
    J Inherit Metab Dis; 2022 May; 45(3):529-540. PubMed ID: 35218577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening and molecular features of patients with multiple acyl-CoA dehydrogenase deficiency in Quanzhou, China.
    Lin Y; Zhang W; Chen Z; Lin C; Lin W; Fu Q; Peng W; Chen D
    J Pediatr Endocrinol Metab; 2021 May; 34(5):649-652. PubMed ID: 33823107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient multiple acyl-CoA dehydrogenation deficiency in a newborn female caused by maternal riboflavin deficiency.
    Chiong MA; Sim KG; Carpenter K; Rhead W; Ho G; Olsen RK; Christodoulou J
    Mol Genet Metab; 2007; 92(1-2):109-14. PubMed ID: 17689999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and molecular investigation of 37 Japanese patients with multiple acyl-CoA dehydrogenase deficiency: p.Y507D in
    Yamada K; Osawa Y; Kobayashi H; Bo R; Mushimoto Y; Hasegawa Y; Yamaguchi S; Taketani T
    Mol Genet Metab Rep; 2022 Dec; 33():100940. PubMed ID: 36406819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience.
    Maguolo A; Rodella G; Dianin A; Nurti R; Monge I; Rigotti E; Cantalupo G; Salviati L; Tucci S; Pellegrini F; Molinaro G; Lupi F; Tonin P; Pasini A; Campostrini N; Ion Popa F; Teofoli F; Vincenzi M; Camilot M; Piacentini G; Bordugo A
    Mol Genet Metab Rep; 2020 Sep; 24():100632. PubMed ID: 32793418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel
    Fan X; Xie B; Zou J; Luo J; Qin Z; D'Gama AM; Shi J; Yi S; Yang Q; Wang J; Luo S; Chen S; Agrawal PB; Li Q; Shen Y
    Mol Genet Metab Rep; 2018 Sep; 16():15-19. PubMed ID: 29988809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating second-tier genetic screening for multiple acyl-CoA dehydrogenase deficiency.
    Lin Y; Zheng W; Chen Y; Huang C; Fu Q; Chen D; Peng W
    Clin Chim Acta; 2022 Dec; 537():181-187. PubMed ID: 36334790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
    Missaglia S; Tavian D; Moro L; Angelini C
    Lipids Health Dis; 2018 Nov; 17(1):254. PubMed ID: 30424791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of multiple acyl-CoA dehydrogenase deficiency in newborns and follow-up of patients.
    Zhou D; Ye M; Hu Z; Zhang Y; Zhu L; Yang R; Huang X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):454-462. PubMed ID: 34704421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card.
    Wood JC; Magera MJ; Rinaldo P; Seashore MR; Strauss AW; Friedman A
    Pediatrics; 2001 Jul; 108(1):E19. PubMed ID: 11433098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational analysis of the riboflavin-responsive ETF:QO-p.Pro456Leu variant associated with mild multiple acyl-CoA dehydrogenase deficiency.
    Lucas TG; Henriques BJ; Gomes CM
    Biochim Biophys Acta Proteins Proteom; 2020 Jun; 1868(6):140393. PubMed ID: 32087359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: High Incidence of Detected Patients With Expanded Newborn Screening Program.
    Remec ZI; Groselj U; Drole Torkar A; Zerjav Tansek M; Cuk V; Perko D; Ulaga B; Lipovec N; Debeljak M; Kovac J; Battelino T; Repic Lampret B
    Front Genet; 2021; 12():648493. PubMed ID: 33986768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lethal Undiagnosed Very Long-Chain Acyl-CoA Dehydrogenase Deficiency with Mild C14-Acylcarnitine Abnormalities on Newborn Screening.
    Spiekerkoetter U; Mueller M; Sturm M; Hofmann M; Schneider DT
    JIMD Rep; 2012; 6():113-5. PubMed ID: 23430948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.